Effects of piperacillin-tazobactam use on the prevalence rate of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in hematology and oncology units
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Escherichia coli infections; Gram-positive infections; Klebsiella infections
- Focus Therapeutic Use
- Sponsors Wyeth
Most Recent Events
- 16 Mar 2007 New trial record.